TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
31 hedge funds and large institutions have $14.6M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$63K
Puts
$3K
Top Buyers
| 1 | +$596K | |
| 2 | +$99.9K | |
| 3 | +$67K | |
| 4 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
+$14.9K |
| 5 |
BlackRock
New York
|
+$5.78K |
Top Sellers
| 1 | -$579K | |
| 2 | -$76K | |
| 3 | -$70.8K | |
| 4 |
Two Sigma Investments
New York
|
-$67K |
| 5 |
Millennium Management
New York
|
-$57K |